Results 91 to 100 of about 1,115 (163)

Platelet response to avatrombopag among patients with primary immune thrombo-cytopenia who switched from eltrombopag or romiplostim: REAL-AVA 2.0 real-world study

Thrombopoietin receptor agonists (TPO-RAs), including eltrombopag (ELT), romiplostim (ROMI), and avatrombopag (AVA), are United States Food and Drug Administration (FDA)-approved treatments for chronic immune thrombocytopenia (ITP), an autoimmune ...
Shruti Chaturvedi, Elyse Swallow, Alexandra Greatsinger, Abiola Oladapo, Sinia Sareen, Chelsea Bernheisel, Michael Vredenburg, Srikanth Nagalla, Debbie Goldschmidt, Loren Ormenaj, Scott Kolodny   +10 more
core   +1 more source

Avatrombopag [PDF]

, 2020
openaire   +1 more source

Correction to: Avatrombopag: A Review in Thrombocytopenia [PDF]

Drugs, 2021
openaire   +1 more source

Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag [PDF]

, 2023
Saartje Van de Vondel, Christophe Vandenbriele, Vandenbriele, Christophe, Gheysens, Gerald, Janssens, Ann, Gerald Gheysens, Van de Vondel, Saartje, Verhamme, Peter, Peter Verhamme, Ann Janssens   +9 more
core   +1 more source

Avatrombopag Maleate [PDF]

, 2020
openaire   +1 more source

A Review of Thrombopoietin Receptor Agonists and Subsequent Development of Thrombosis: Exploring a Hematologic Paradox. [PDF]

Cureus
Graifman G, Parekh R, C P RV, Nair A.
europepmc   +1 more source

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI). [PDF]

Br J Haematol
Pascual-Izquierdo C, Bastida JM, Valcárcel D, Sánchez-González B, Mingot-Castellano ME, Canaro-Hirnyk M, Aguilar-Monserrate G, Ortiz-López A, Carbonell S, García-Lázaro S, Martín-Carrizosa A, Alonso-Martínez C, Alcalde-Mellado P, Pedrote-Amador B, Serrasolses-Alemany E, Remezal-Serrano M, Canet-Maldonado M, Gómez-Del-Castillo MD, Lasa-Eguialde M, García-Jaén P, Carrasco-Macedo S, González-Gascón-Y-Marín I, Zafra D, Fernández-Canal C, Piernas-Fontanilla S, Hernández-Vázquez L, Morales-Espino E, Cobo-Rodríguez T, Martínez-Carballeira D, González-Marugán P, Bolaños-Caderón E, Caballero-Navarro G, Revilla-Calvo N, Arquero-Portero T, Cervera M, Rodríguez-López M, Bañón-Soria J, Ramírez-López A, Álvarez-Román MT, Spanish ITP Group (GEPTI).   +39 more
europepmc   +1 more source

Managing Acute STEMI in the Setting of Immune Thrombocytopenic Purpura: A Therapeutic Dilemma. [PDF]

JACC Case Rep
Jemmieh K, Tawengi M, Baraka J, Mahmood F, Alhaj Akeel FA, Alammora A, Choura MG.   +6 more
europepmc   +1 more source

Thrombopoietin agents and marrow fibrosis: fact or myth. [PDF]

Haematologica
Bussel JB, Hyche MH.
europepmc   +1 more source

Severe Aplastic Anemia in a Patient with Erythropoietic Protoporphyria Successfully Treated by Avatrombopag

, 2021
ZIMING JIANG, Xianyong Jiang, Miao Chen
core   +1 more source